{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:03:04Z","timestamp":1789981384819,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Res."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s44313-026-00166-x","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:07:02Z","timestamp":1789978022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferroptosis-related genes influence AML risk through immune cell\u2013mediated pathways: a Mendelian randomization study with mediation analysis"],"prefix":"10.1007","volume":"61","author":[{"given":"Qi","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"166_CR1","doi-asserted-by":"crossref","unstructured":"Shai S, Maximilian S, Richard MS. Acute myeloid leukemia: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol. 2025;100(5):860-91.","DOI":"10.1002\/ajh.27625"},{"key":"166_CR2","first-page":"101664","volume":"61","author":"Q Liu","year":"2025","unstructured":"Liu Q, Hu Z, Xu N, Jiang Y, Fan Z, Huang F, et al. Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trial. Lancet Reg Health West Pac. 2025;61:101664.","journal-title":"Lancet Reg Health West Pac"},{"key":"166_CR3","doi-asserted-by":"crossref","unstructured":"Jialing T, Xibo Y, Zhangyang X, Tianjiao M, Zherun T, Li M, Ying H, Beier J. Epigenetic mechanisms of drug resistance in acute myeloid leukemia: advances in small-molecule targeted therapy. Front Pharmacol. 2025;16:1672524.","DOI":"10.3389\/fphar.2025.1672524"},{"key":"166_CR4","doi-asserted-by":"crossref","unstructured":"Artemis Margrith B, Jana Maria E. Inflammatory signaling in the pathogenesis of acute myeloid leukemia. Hemasphere. 2025;9(8):e70188.","DOI":"10.1002\/hem3.70188"},{"key":"166_CR5","doi-asserted-by":"crossref","unstructured":"Michael W, Marina K, Shane M. Novel therapeutic targets in Acute Myeloid Leukemia (AML). Curr Oncol Rep. 2024;26(4):409\u201320.","DOI":"10.1007\/s11912-024-01503-y"},{"key":"166_CR6","doi-asserted-by":"crossref","unstructured":"Ugochi E, Binsah G. Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies. Discov Oncol. 2025;16(1):89.","DOI":"10.1007\/s12672-025-01797-9"},{"key":"166_CR7","doi-asserted-by":"crossref","unstructured":"Scott JD, Kathryn ML, Michael RL, Rachid S, Eleina MZ, Caroline EG, Darpan NP, Andras JB, Alexandra MC, Wan Seok Y, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","DOI":"10.1016\/j.cell.2012.03.042"},{"key":"166_CR8","doi-asserted-by":"crossref","unstructured":"Farzaneh T, Mohammad Ali A, Fatemeh K, Hamed SS, Hoda H, Elham R, Nader VS, Ali D, Mohammad Hossein M. Ferroptosis in AML: nanoparticles, biomarkers, and immune rewiring for therapeutic breakthroughs. Discov Oncol. 2025;16(1):1937.","DOI":"10.1007\/s12672-025-03777-5"},{"key":"166_CR9","doi-asserted-by":"crossref","unstructured":"Xin L, Shuxin Z, Kangjie Q, Xi C, Weiyue W, Jiamian Z, Yanwen L, Haolong W, Shiyun F, Dingrui N, et al. Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis. Exp Hematol Oncol. 2023;12(1):47.","DOI":"10.1186\/s40164-023-00411-4"},{"key":"166_CR10","doi-asserted-by":"crossref","unstructured":"Zhiyuan Z, Xiaoying H, Xiaoxue H, Xiandong J, He J, Yingying H, Wei W, Yan X, Donghong L. Comprehensive analysis of ferroptosis-related gene signatures as a potential therapeutic target for acute myeloid leukemia: a bioinformatics analysis and experimental verification. Front Oncol. 2022;12:930654.","DOI":"10.3389\/fonc.2022.930654"},{"key":"166_CR11","doi-asserted-by":"crossref","unstructured":"Lijun J, Biyu Z, Jinghui S, Jueping F, Denggang F. Prognostic insights and immune microenvironment delineation in acute myeloid leukemia by ferroptosis-derived signature. Heliyon. 2024;10(6):e28237.","DOI":"10.1016\/j.heliyon.2024.e28237"},{"key":"166_CR12","doi-asserted-by":"crossref","unstructured":"Rina K, Devon T, Robert HV, Dmitry IG. Ferroptosis of immune cells in the tumor microenvironment. Trends Pharmacol Sci. 2023;44(8):542\u201352.","DOI":"10.1016\/j.tips.2023.06.005"},{"key":"166_CR13","doi-asserted-by":"crossref","unstructured":"Yilan H, Siwei W, Aiwu K, Kun G. Ferroptosis and its interaction with tumor immune microenvironment in liver cancer. Biochim Biophys Acta Rev Cancer. 2022;1878(1):188848.","DOI":"10.1016\/j.bbcan.2022.188848"},{"key":"166_CR14","doi-asserted-by":"crossref","unstructured":"Gian Luca LT, Emily NA, Denis AM, Kelsey V. Immunometabolism of ferroptosis in the tumor microenvironment. Front Oncol. 2024;14:1441338.","DOI":"10.3389\/fonc.2024.1441338"},{"key":"166_CR15","doi-asserted-by":"crossref","unstructured":"Yan Z, Liyi Z, Xiaodan L, Long G, Baoguang H, Hua Y, Yi L. SLC40A1 in iron metabolism, ferroptosis, and disease: a review. WIREs Mech Dis. 2024;16(4):e1644.","DOI":"10.1002\/wsbm.1644"},{"key":"166_CR16","doi-asserted-by":"crossref","unstructured":"Shin Young H, Eun Jung N, Ji Eun J, Haerim C, Soo Jeong K, Jin Seok K, Jee Hyun K, Kwang Yong S, Jong In L, Yoo Hong M, et al. Immunosuppressive role of CD11b(+) CD33(+) HLA-DR(-) myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia. Cancer Med. 2020;9(19):7007\u201317.","DOI":"10.1002\/cam4.3360"},{"key":"166_CR17","doi-asserted-by":"crossref","unstructured":"Giuseppe Alberto P, Nunziatina Laura P, Cesarina G, Emanuele DA, Aurora Z, Fabrizio P, Concetta C, Annalisa C, Daniele T, Francesco Di R, et al. Monocytic myeloid derived suppressor cells in hematological malignancies. Int J Mol Sci. 2019;20(21):5366.","DOI":"10.3390\/ijms20215459"},{"key":"166_CR18","doi-asserted-by":"crossref","unstructured":"Iosif P, Efrosyni M, Christina K, Panayotis V. Decoding the myeloid-derived suppressor cells in lymphoid malignancies. J Clin Med. 2021;10(16):3462.","DOI":"10.3390\/jcm10163462"},{"key":"166_CR19","doi-asserted-by":"crossref","unstructured":"Qian K, Qixiang L, Yinli T, Xiangqin L, Yesheng L, Xiaofeng L, Yun C, Huiqin C. Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1\/ACSL4 pathway. Int J Oncol. 2024;66(1):2.","DOI":"10.3892\/ijo.2024.5708"},{"key":"166_CR20","doi-asserted-by":"crossref","unstructured":"Kang W, Zhengyang Z, Hsiang-I T, Yanfang L, Jie G, Ming W, Lian S, Xiongfeng C, Zhanxue X, Hongbo C, et al. Branched-chain amino acid aminotransferase 2 regulates ferroptotic cell death in cancer cells. Cell Death Differ. 2020;28(4):1222\u201336.","DOI":"10.1038\/s41418-020-00644-4"},{"key":"166_CR21","doi-asserted-by":"crossref","unstructured":"Can C, Hassan N, Keping C. Research progress on branched-chain amino acid aminotransferases. Front Genet. 2023;14:1233669.","DOI":"10.3389\/fgene.2023.1233669"},{"key":"166_CR22","doi-asserted-by":"crossref","unstructured":"Miao Z, You Y, Jing L, Ling G, Qulian G, Wenjun L. Bone marrow immune cells and drug resistance in acute myeloid leukemia. Exp Biol Med (Maywood). 2025;250:10235.","DOI":"10.3389\/ebm.2025.10235"},{"key":"166_CR23","unstructured":"Jing L, Hao Z, Dong J, Yiran L, Tao Y. Uncovering the role of RPL8 in glutathione synthesis-dependent ferroptosis control in hepatocellular carcinoma. Arch Med Sci. 2024;21(4):1513\u201335."},{"key":"166_CR24","doi-asserted-by":"crossref","unstructured":"Gianmarco S, Francesca P, Florelle G, Lucia C, Roberta DP. The role of the CREB protein family members and the related transcription factors in radioresistance mechanisms. Life (Basel). 2021;11(12):1437.","DOI":"10.3390\/life11121437"},{"issue":"3","key":"166_CR25","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1182\/blood-2007-04-083600","volume":"111","author":"JC Cheng","year":"2008","unstructured":"Cheng JC, Kinjo K, Judelson DR, Chang J, Wu WS, Schmid I, et al. CREB is a critical regulator of normal hematopoiesis and leukemogenesis. Blood. 2008;111(3):1182\u201392.","journal-title":"Blood"},{"key":"166_CR26","doi-asserted-by":"publisher","first-page":"634292","DOI":"10.1155\/2009\/634292","volume":"2009","author":"S Sandoval","year":"2009","unstructured":"Sandoval S, Pigazzi M, Sakamoto KM. CREB: a key regulator of normal and neoplastic hematopoiesis. Adv Hematol. 2009;2009:634292.","journal-title":"Adv Hematol"},{"issue":"1","key":"166_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12916-022-02409-x","volume":"20","author":"T Tong","year":"2022","unstructured":"Tong T, Qin X, Jiang Y, Guo H, Wang X, Li Y, et al. A novel CREB5\/TOP1MT axis confers cisplatin resistance through inhibiting mitochondrial apoptosis in head and neck squamous cell carcinoma. BMC Med. 2022;20(1):231.","journal-title":"BMC Med"},{"issue":"14","key":"166_CR28","doi-asserted-by":"publisher","first-page":"e7471","DOI":"10.1002\/cam4.7471","volume":"13","author":"C Yamada","year":"2024","unstructured":"Yamada C, Okada K, Odaira K, Tokoro M, Iwamoto E, Sanada M, et al. RGS1 and CREB5 are direct and common transcriptional targets of ZNF384-fusion proteins. Cancer Med. 2024;13(14):e7471.","journal-title":"Cancer Med"},{"key":"166_CR29","doi-asserted-by":"crossref","unstructured":"Stephanie S, Dirk R, Naghmeh N. Redirecting the immune microenvironment in acute myeloid leukemia. Cancers (Basel). 2021;13(6):1423.","DOI":"10.3390\/cancers13061423"}],"container-title":["Blood Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-026-00166-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44313-026-00166-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-026-00166-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:07:19Z","timestamp":1789978039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44313-026-00166-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["166"],"URL":"https:\/\/doi.org\/10.1007\/s44313-026-00166-x","relation":{},"ISSN":["2287-979X","2288-0011"],"issn-type":[{"value":"2287-979X","type":"print"},{"value":"2288-0011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"5 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Because the data used in our study were obtained from existing databases, no additional ethical review was required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"57"}}